Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors...Read more
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership. As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, is positioned to enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Kevin O’Neill, President & CEO of GE HealthCare’s Pharmaceutical Diagnostics segment, will...Read more
GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes. Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by 2030.iii The average number of cardiac...Read more
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, is now available in select U.S. markets and has been granted traditional pass-through payment status by the U.S. Centers for Medicare and Medicaid. CHICAGO / Mar 27, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the...Read more
The latest Invenia ABUS is designed to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology Invenia ABUS Premium features new integrated Verisound AI and AI Assistant, which ensure faster and reproducible scanning and reading with extraordinary image quality The non-invasive ultrasound technology, equipped with a novel Reverse Curve transducer and separate acquisition and reading...Read more
Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing burden on healthcare professionals. SAN JOSE, Calif. / Mar 18, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to...Read more
AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab can enhance efficiency and precision care for multiple types of cardiac procedures CHICAGO / Mar 17, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and...Read more
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and PLEASANTON, Calif., March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine...Read more
Fiscal Year 2025 Total Revenues of $2,746.6M, up 16% Year Over Year Q4 Total Revenues of $720.9M, up 14% Year Over Year Fiscal Year 2025 Subscription Services Revenues of $2,284.7M, up 20% Year Over Year Q4 Subscription Services Revenues of $608.6M, up 17% Year Over Year PLEASANTON, Calif., March 5, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life...Read more
A new cloud-suite of enterprise imaging solutions, the Genesis portfolio, is designed to help improve patient care coordination, reduce operational costs, and maintain robust security standards Allows healthcare providers to more easily store, access, and manage large volumes of medical images from anywhere, anytime Demonstrates GE HealthCare’s commitment to increasing the number of cloud-enabled product offerings by 2028, generating...Read more
Freelium, a helium-freei sealed magnet platform in development, aims to dramatically reduce liquid helium usage without sacrificing power efficiency, operational security and clinical performance Leveraging GE HealthCare’s proven lightweight, intelligent magnet technology, Freelium will be optimized to seamlessly integrate with future technological advancements and upgrade options, offering flexibility and reliability for imaging...Read more
The first patient doses of GE HealthCare’s new FDA-approved PET radiotracer, Flyrcado™ (flurpiridaz F 18) injection, are being administered at early adopter sites around the United States. First-of-its-kind radiopharmaceutical, Flyrcado, a PET myocardial perfusion imaging (MPI) agent, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, the predominant procedure...Read more
Fourth Quarter 2024 Revenue growth was 2% year-over-year; Organic revenue growth* was 2% Net income margin was 13.5% versus 7.7% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 18.7% versus 16.1% Diluted earnings per share (EPS) were $1.57 versus $0.88 for the prior year; Adjusted EPS* was $1.45 versus $1.18 Cash flow from operating activities was $913 million versus $1.1 billion for the prior year;...Read more
New $138 million facility at GE HealthCare’s Cork manufacturing site will enable 25 million more patient doses of contrast media per year by the end of 2027i Demand for CT and X-Ray contrast media, used to enhance medical imaging procedures globally, is estimated to double in the next ten yearsii Investment will create additional capacity to cater for growing demand, while offering increased flexibility and resiliency for security of...Read more
Total revenues for 2024 increased 27% to $247.1 billion Shareholders' net income for 2024 was $3.4 billion, or $12.12 per share Adjusted income from operations1 for 2024 was $7.7 billion, or $27.33 per share 2025 adjusted income from operations1,2 is projected to be at least $7.9 billion, or at least $29.50 per share Board of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of...Read more
Latest Voluson Expert 22, 20 and 18 ultrasound systems harness artificial intelligence and advanced tools and software for more efficient assessments Voluson Expert Series delivers elevated performance, with focus on first trimester to reveal clearer anatomical details, aiding earlier detection and boosting diagnostic confidence CHICAGO / Jan 28, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced it has received...Read more
NASHVILLE, Tenn. / Jan 24, 2025 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an...Read more
Integration will reduce the burden of master lab data configuration, lowering costs and speeding Veeva LIMS implementation PLEASANTON, Calif. and DEERFIELD, Ill., Jan. 23, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and Zifo today announced a product partnership to help biopharmas modernize quality control (QC) operations. By bringing together Veeva LIMS with Zifo's data integration and management platform, qcKen, companies can...Read more
4Q 2024 operating revenue of $45.0 billion; FY 2024 of $175.2 billion 4Q 2024 diluted EPS1 of $1.81; adjusted diluted EPS2 of $3.84 FY 2024 diluted EPS1 of $25.68; adjusted diluted EPS2 of $33.04 Projected FY 2025 GAAP diluted EPS1 to be in the range of $30.40 to $31.10 Projected FY 2025 adjusted diluted EPS2 to be in the range of $34.15 to $34.85 Quarterly dividend increased by 5% to $1.71 per share INDIANAPOLIS / Jan 23, 2025 /...Read more
Revenues of $400.3 Billion Grew 8% Year-Over-Year Domestic Consumers Served by UnitedHealthcare Grew 2.1 Million Value-Based Care Patients Served by Optum Grew 600,000 Cash Flows from Operations were $24.2 Billion or 1.6x Net Income Full Year, Fourth Quarter Net Earnings were $15.51, $5.98 Per Share Full Year, Fourth Quarter Adjusted Net Earnings were $27.66, $6.81 Per Share Company Affirms 2025 Performance Outlook - / Jan 16,...Read more
New joint research program combines UCSF’s advanced clinical and research teams with GE HealthCare’s technical and engineering expertise to develop solutions that directly impact patient care. The collaboration aims to address two of the most prevalent disease states worldwide, neurodegenerative disease and cancer, by increasing accessibility of imaging, driving clinical impact and translating techniques to diagnose and treat these...Read more
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians with access to technology advances and innovations. It will also drive ongoing, comprehensive training and education, fostering future healthcare professionals representing the diverse communities they serve. Sutter Health, one of the top integrated health delivery systems in the country...Read more
Total Revenues of $699.2M, up 13% Year Over Year Subscription Services Revenues of $580.9M, up 17% Year Over Year PLEASANTON, Calif., Dec. 5, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its third quarter ended October 31, 2024. "It was a great quarter of innovation and excellent execution across the...Read more
More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare is at the forefront of leveraging deep learning, a subset of artificial intelligence (AI), to benefit clinicians and patients with the latest technologies and solutions. CHICAGO / Dec 05, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC)...Read more
CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing CBCT data CHICAGO / Dec 03, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve the quality of cone-beam...Read more
GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, will enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease Acquisition positions NMP to become partner of choice for global innovators looking to bring novel...Read more
New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR Recon DL accelerates workflow while improving diagnostic confidence and patient comfort. CHICAGO / Dec 01, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging...Read more
Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product introductions reflect GE HealthCare’s increased R&D investment since 2022 CHICAGO / Dec 01, 2024 / Business Wire / At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare...Read more
Amid technologist shortage, new mammography innovation was designed through intensive collaboration with technologists will help to streamline workflow and humanize care CHICAGO / Nov 26, 2024 / Business Wire / Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America’s 2024 Annual...Read more
CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM SINGAPORE, Nov. 24, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities, companies can deploy AI that will...Read more
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-CBCT offering. OEC Open interface expanded with additional third-party option to streamline data interface during bronchoscopy procedures. CHICAGO / Nov 22, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) announces additional clinical applications now available as part of the OEC 3D...Read more
CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM MADRID and PLEASANTON, Calif., Nov. 20, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Vault CRM Bot and Vault CRM Voice Control, two new GenAI capabilities in Vault CRM. Unveiled at Veeva Commercial Summit Europe, CRM Bot and Voice Control join a host of new innovations coming to Vault CRM next year. With these new capabilities,...Read more
PLEASANTON, Calif., Nov. 19, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its new cloud-based digital Hazard Analysis and Critical Control Point (HACCP) solution. Delivering HACCP management as part of the Veeva QualityOne Suite will help food and beverage manufacturers streamline food safety and quality processes, improve visibility and control over critical risks, and enable proactive quality management and compliance...Read more
Published in the Journal of Clinical Anesthesia, results from the two-phase, 250 patient pilot study show clinicians found a majority (82%) of the alarms from the wireless and wearable Portrait Mobile monitoring solution to be informative or useful to optimize patient care in medical-surgical units.1 Study findings suggest that continuous monitoring helps provide critical information to clinicians, enabling them to intervene effectively...Read more
New MRI technology aims to advance neuroimaging and biomarker research CHICAGO / Nov 13, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner. This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological,...Read more
Factors impacting today’s critical shortage of radiologic technologists include clinician burnout, the impact of COVID and COVID-related policies, and demand for radiologic technologists outpacing today’s number of trained clinicians. GE HealthCare and AMN Healthcare are working together to enable training and development of the next generation of radiologic technologists to help address this critical clinician shortage and support...Read more
Total revenues for the third quarter 2024 increased 30% to $63.7 billion Shareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per share Adjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per share Reaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per share BLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The...Read more
Revenue growth was 1% year-over-year; Organic revenue growth* was 1% Net income margin was 9.7% versus 7.8% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 16.3% versus 15.4% Diluted earnings per share (EPS) were $1.02 versus $0.83 for the prior year; Adjusted EPS* was $1.14 versus $0.99 Cash flow from operating activities was $742 million versus $650 million for the prior year; Free cash flow* was...Read more
NASHVILLE, Tenn. / Oct 25, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an...Read more
DEERFIELD, Ill. and PLEASANTON, Calif., Oct. 24, 2024 /PRNewswire/ -- Walgreens (Nasdaq: WBA), an integrated healthcare, pharmacy, and retail leader, and Veeva Systems (NYSE: VEEV) a leading provider of software, data, and services for the life sciences industry, today announced a long-term partnership to help life sciences companies improve patient outcomes.\ The partnership enriches Veeva Data Cloud products and...Read more
Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s history, spotlighting disease progression and helping to inform proactive interventions Tampa General Hospital and UT Southwestern Medical Center to be early evaluators of CareIntellect for Oncology Application is the first within GE HealthCare’s new CareIntellect offering of clinical and operational applications, built to...Read more
Innovations include Health Companion research project powered by agentic AI Additional early innovations explore pressing care needs, including identifying new ways to detect breast cancer and improving quality of care for moms and babies CHICAGO / Oct 21, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new AI Innovation Lab, an initiative designed to accelerate early-concept AI innovations within the company....Read more
GE HealthCare announces Hospital Pulse, the newest tile for its Command Center Software Platform CHICAGO / Oct 17, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a new tile for its Command Center Software: Hospital Pulse. Hospital Pulse Tile pulls in real-time information from across departments to quickly surface the most vital information about a healthcare system’s operations in a customizable dashboard designed...Read more
3Q 2024 operating revenue of $44.7 billion 3Q 2024 adjusted operating gain1 of $2.4 billion 3Q 2024 diluted EPS2 of $4.36; adjusted diluted EPS1 of $8.37 4Q 2024 dividend of $1.63 per share declared to shareholders INDIANAPOLIS / Oct 17, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported third quarter 2024 results. “We remain confident in the long-term earnings potential of our diverse businesses as we navigate a...Read more
Bringing together leading global healthcare innovator and European healthcare institutions, this relationship aims to advance Theranostics in clinical practice and the development of new tracers and technologies for more personalized medicine Theranostics is a transformative approach to cancer treatment, giving hope to patients and their loved ones and the potential for an improved quality of life The practice of Theranostics is...Read more
Revenues of $100.8 Billion Grew $8.5 Billion Year Over Year Consumers Served by UnitedHealthcare’s Commercial Domestic Offerings Grew 2.4 Million Year to Date Third Quarter Earnings of $6.51 Per Share Include Cyberattack Impacts Adjusted Earnings of $7.15 Per Share Include $0.12 in Business Disruption Impacts; Exclude $0.28 Direct Response Costs Oct 15, 2024 / Business Wire / UnitedHealth Group (NYSE: UNH) reported third quarter...Read more
Versana Premier is designed to feel familiar from day one, simplifying workflow and making it easier for clinicians in multiple-purpose practices to deliver high-quality care to a wide range of patient populations and care scenarios Powered by VisionBoost Architecture, Versana Premier offers an advanced imaging platform designed to deliver exceptional image quality with its next generation image engine, first-class display technology,...Read more
Integrated feature from Blackford offers AI-enabled decision support to help radiologists adapt to higher workloads and increased exam complexity CHICAGO / Oct 09, 2024 / Business Wire / GE HealthCare integrates third party artificial intelligence (AI)-enabled application orchestration feature into True PACS and Centricity PACS. 1 In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which...Read more
CHICAGO / Oct 07, 2024 / Business Wire / GE HealthCare announces the commencement, and its leading industrial role, in Thera4Care, an initiative aimed at revolutionizing the use of theranostics to broaden patient access in Europe. The €25.3 million project gathers 29 partners from top European academic and clinical sites, small and medium-sized enterprises, and patient advocacy groups. Cancer is the leading cause of death worldwide,...Read more
Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well tolerated with no serious adverse events, dose-limiting toxicities or clinically relevant findings reported. If approved, this agent could provide an alternative to gadolinium-based contrast agents and address the potential impact of post-patient...Read more
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, the predominant procedure used in nuclear cardiology today With a half-life over ten times longer than currently approved cardiac PET radiotracers, Flyrcado brings the first practical opportunity to combine exercise stress testing with...Read more
Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning and support at the point of care Venue family enhancements include advanced software and wireless flexibility with the integration of Vscan Air™ probes CHICAGO / Sep 19, 2024 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of enhanced Venue ultrasound systems and a new...Read more
E-Treatment services powered through MDLIVE by Evernorth routinely deliver customers diagnoses and treatment plans within one hour without any direct interaction Now available to U.S. Cigna Healthcare customers who have coverage through the individual marketplace or their employer BLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), launched an "E-Treatment"...Read more
Expanded suite to unify sales, marketing, medical and service through a connected software and data foundation SINGAPORE, Sept. 5, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Service Center for inside sales, contact center, and hybrid reps in APAC. Supporting inbound and outbound engagement across channels, Vault CRM Service Center enables life sciences companies to eliminate siloes among...Read more
New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect PLEASANTON, Calif., Sept. 5, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced, in a major step forward for clinical trial execution, the newest release of Veeva Site Connect, adding...Read more
Estimated to save individual Accredo patients around $4,000 per year Biosimilar price will be more than 80% lower than Stelara list price Accredo patients benefit from the specialty pharmacy's best-in-class clinical support BLOOMFIELD, Conn., Sept. 5, 2024 /PRNewswire/ -- Evernorth Health Services announced that it plans to have a Stelara biosimilar available for $0 out of pocket for eligible patients of its specialty...Read more
Total Revenues of $676.2M, up 15% Year Over Year; Subscription Services Revenues of $561.3M, up 19% Year Over Year PLEASANTON, Calif., Aug. 28, 2024 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced results for its second quarter ended July 31, 2024. "It was another quarter of great execution, with major product advances in...Read more
Life sciences organizations now manage all quality control data and processes in one solution for greater efficiency and speed PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced increasing momentum for Veeva Vault LIMS, a modern cloud solution that simplifies end-to-end quality control (QC) business processes. Vault LIMS is unified with Veeva Vault Quality, enabling customers to share...Read more
Published in Anesthesia and Analgesia, results from the multi-site trial evaluating End-tidal Control software provide compelling evidence for enhanced accuracy and efficiency of anesthesia delivery compared to conventional anesthetic gas delivery methods.1 End-tidal Control is the first FDA-approved software that automatically adjusts and maintains exhaled oxygen and exhaled anesthetic concentrations, with more accuracy in reaching the...Read more
Total revenues for the second quarter 2024 increased 25% to $60.5 billion Shareholders' net income for the second quarter 2024 was $1.5 billion, or $5.45 per share Adjusted income from operations1 for the second quarter 2024 was $1.9 billion, or $6.72 per share 2024 outlook2 for adjusted income from operations1,2 is at least $28.40 per share BLOOMFIELD, Conn., Aug. 1, 2024 /PRNewswire/ -- Global health company The Cigna Group...Read more
Revenues were flat year-over-year; Organic revenue growth* was 1% Net income margin was 8.9% versus 8.7% for the prior year; Adjusted earnings before interest and taxes (EBIT) margin* was 15.3% versus 14.8% Diluted earnings per share (EPS) were $0.93 versus $0.91 for the prior year; Adjusted EPS* was $1.00 versus $0.92 Cash flow from operating activities was $(119) million versus $(67) million for the prior year; Free cash flow* was...Read more
New Veeva Pulse findings show congresses and early-career experts have the strongest influence on patient outcomes PLEASANTON, Calif., July 25, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams' impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing in pre-launch scientific activities...Read more
GE HealthCare selects AWS as its strategic cloud provider to deliver entirely new, purpose-built foundation models designed to fast-track the development of innovative healthcare applications GE HealthCare plans to train and deploy clinical foundation models on AWS’s machine learning and generative AI technologies to help healthcare providers expedite clinical and operational workflows to improve delivery of care CHICAGO / Jul 25,...Read more
Raises 2024 Guidance NASHVILLE, Tenn. / Jul 23, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted...Read more
Agreement to acquire business adds innovative, real-time image recognition technology and expertise to GE HealthCare’s portfolio of AI-enabled devices AI-based technology from Intelligent Ultrasound aims to provide real-time support for OBGYN scans and improve exam accuracy and efficiency Planned acquisition supports GE HealthCare’s precision care strategy to address inefficiencies and improve patient care quality CHICAGO / Jul 18,...Read more
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain1 of $2.8 billion 2Q 2024 diluted EPS2 of $9.85, up 26%; adjusted diluted EPS1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders INDIANAPOLIS / Jul 17, 2024 / Business Wire / Elevance Health, Inc. (NYSE: ELV) reported second quarter 2024 results. “Second quarter results reflect the power of our diversified business and thoughtful...Read more
Revenues of $98.9 Billion Grew Nearly $6 Billion Year Over Year, Led by Optum Consumers Served by UnitedHealthcare’s Commercial Domestic Offerings Grew 2.3 Million Year to Date Cash Flows from Operations were $6.7 Billion or 1.5x Net Income Second Quarter Earnings of $4.54 Per Share Reflect Classification of Remaining South American Operations as Held for Sale and Cyberattack Impacts Adjusted Earnings of $6.80 Per Share Include $0.28...Read more
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE